Cargando…

Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma

BACKGROUND: Portal vein tumour thrombus (PVTT) is highly associated with the progression and metastasis of hepatocellular carcinoma (HCC). However, there are no appropriate cell models of PVTT with which to study the biological and physiological characteristics of PVTT. METHODS: Primary cell culture...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, T, Hu, H S, Feng, Y X, Shi, J, Li, N, Guo, W X, Xue, J, Xie, D, Liu, S R, Wu, M C, Cheng, S Q
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883151/
https://www.ncbi.nlm.nih.gov/pubmed/20461085
http://dx.doi.org/10.1038/sj.bjc.6605689
_version_ 1782182236613771264
author Wang, T
Hu, H S
Feng, Y X
Shi, J
Li, N
Guo, W X
Xue, J
Xie, D
Liu, S R
Wu, M C
Cheng, S Q
author_facet Wang, T
Hu, H S
Feng, Y X
Shi, J
Li, N
Guo, W X
Xue, J
Xie, D
Liu, S R
Wu, M C
Cheng, S Q
author_sort Wang, T
collection PubMed
description BACKGROUND: Portal vein tumour thrombus (PVTT) is highly associated with the progression and metastasis of hepatocellular carcinoma (HCC). However, there are no appropriate cell models of PVTT with which to study the biological and physiological characteristics of PVTT. METHODS: Primary cell culture was performed by the use of a successive xenograft line called PVTT-#1, which was obtained from a 60-year-old male HCC patient accompanied by PVTT. RESULTS: A successive cell line named CSQT-2 was established. The cell line showed aggressive phenotypes in terms of cell growth, survival, migration, xenograft and metastasis. Moreover, an orthotopic transplantation assay showed that PVTT can be generated in nude mice when CSQT-2 cells were inoculated in the liver and that it shows a typical migratory tendency in the vascular branches of portal vein. Moreover, the established CSQT-2 cells also showed varied expression of tumour-initiating cell (TIC) markers such as CD133, CD90 and EpCAM. CONCLUSION: Establishment of CSQT-2 may provide a suitable model with which to investigate the molecular mechanisms of PVTT-related HCC.
format Text
id pubmed-2883151
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-28831512011-05-25 Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma Wang, T Hu, H S Feng, Y X Shi, J Li, N Guo, W X Xue, J Xie, D Liu, S R Wu, M C Cheng, S Q Br J Cancer Molecular Diagnostics BACKGROUND: Portal vein tumour thrombus (PVTT) is highly associated with the progression and metastasis of hepatocellular carcinoma (HCC). However, there are no appropriate cell models of PVTT with which to study the biological and physiological characteristics of PVTT. METHODS: Primary cell culture was performed by the use of a successive xenograft line called PVTT-#1, which was obtained from a 60-year-old male HCC patient accompanied by PVTT. RESULTS: A successive cell line named CSQT-2 was established. The cell line showed aggressive phenotypes in terms of cell growth, survival, migration, xenograft and metastasis. Moreover, an orthotopic transplantation assay showed that PVTT can be generated in nude mice when CSQT-2 cells were inoculated in the liver and that it shows a typical migratory tendency in the vascular branches of portal vein. Moreover, the established CSQT-2 cells also showed varied expression of tumour-initiating cell (TIC) markers such as CD133, CD90 and EpCAM. CONCLUSION: Establishment of CSQT-2 may provide a suitable model with which to investigate the molecular mechanisms of PVTT-related HCC. Nature Publishing Group 2010-05-25 2010-05-11 /pmc/articles/PMC2883151/ /pubmed/20461085 http://dx.doi.org/10.1038/sj.bjc.6605689 Text en Copyright © 2010 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular Diagnostics
Wang, T
Hu, H S
Feng, Y X
Shi, J
Li, N
Guo, W X
Xue, J
Xie, D
Liu, S R
Wu, M C
Cheng, S Q
Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title_full Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title_fullStr Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title_full_unstemmed Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title_short Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
title_sort characterisation of a novel cell line (csqt-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883151/
https://www.ncbi.nlm.nih.gov/pubmed/20461085
http://dx.doi.org/10.1038/sj.bjc.6605689
work_keys_str_mv AT wangt characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT huhs characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT fengyx characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT shij characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT lin characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT guowx characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT xuej characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT xied characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT liusr characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT wumc characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma
AT chengsq characterisationofanovelcelllinecsqt2withhighmetastaticactivityderivedfromportalveintumourthrombusofhepatocellularcarcinoma